Ovid Therapeutics - 53 Year Dividend History | OVID
Historical dividend payout and yield for Ovid Therapeutics (OVID) since 1971. The current TTM dividend payout for Ovid Therapeutics (OVID) as of December 20, 2024 is $0.00. The current dividend yield for Ovid Therapeutics as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.073B |
$0.000B |
|
Ovid Therapeutics Inc. is a biopharmaceutical company. It engaged in developing therapies for patients with rare neurological disorders. The company's product pipeline consists of OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. It also involved in developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid Therapeutics Inc. is based in New York, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
